Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Pharma Marketing Execution turning ideas into real outcomes
Pharma marketing doesn’t fail because of weak ideas. It fails because execution breaks down. In a regulated, crowded, and compliance-heavy industry, even the smartest campaign can collapse without…
|
Doctor Engagement Metric Driving Real Impact in Pharma
Doctor Engagement Metric is the crucial KPI for pharma, linking campaigns to prescriptions by tracking meaningful interactions and building long term trust.
|
Field Force 2.0: Turning 10,000 Reps Into Digital-First Growth Drivers
The End of the Old PlaybookFor decades, pharma believed the field force was the growth engine. Hire more reps. Train them harder. Push for more calls. It worked, until it didn’t.Doctors today don’t…
|
Personalized Patient Support Driving Better Pharma Outcomes
Personalized Patient Support transforms pharma PSPs by focusing on language, context, and patient journeys, improving adherence, trust, and measurable outcomes.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
